2. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. 19%. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. VHT vs XBI. Currency in USD. 91 Billion . Better trading starts here. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. N/A. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. SPDR S&P Biotech ETF is a equity fund issued by SSgA. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. Complete SPDR S&P Biotech ETF funds overview by Barron's. ETFs are subject to market fluctuation and the risks of their underlying investments. 7657M. " The 12-month stock price forecast is $22. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. The split for XBI took place on September 11, 2015. It is gross of any fee waivers or expense reimbursements. Oct 10, 2022 01:14PM EDT. S. Comparing the most. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. XBI ETF's holdings offer significant diversification. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 26%. If Moderna's share price. The index and exchange-traded fund ETF are rebalanced four times a year. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. Immunovant Inc. Its top 10 holdings account for approximately 16. The stock holdings of the XBI tends to be re. 57 billion. XBI has traded between $64. ARGX. . XBI vs ARKG. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. February 15, 2023 — 10:47 am EST. GrowthStrategy: Traditional growth investing is an investment. S. Trader's Guide 2024 Ships December 21st. large-cap stocks. Major Holdings. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. The table below compares many ETF metrics between IBB and XBI. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. 03 per $1,000 of principal). $36. SPDR® S&P Biotech ETF. 2015. 15 billion assets under management. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. S. 88 ; Annual Dividend & Yield 0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. IBB vs. Its fund flows were negative $259. Analyst Forecast. Holdings AS OF 04/30/2023. Performance and Risk. Price Chart. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. Research performance, expense ratio, holdings, and volatility to see if it's the. November 03, 2023 — 10:50 am EDT. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. As of 09/30/2023. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. Additionally. 73m. $0. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 87. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). XBI has a lower 5-year return than XLV (-5. S. 35% for XBI, but SBIO yields 2. 24 per unit, that means that analysts see 75. 80 per share, with $92. NEW: Experience our best charts yet. XBI currently has 133 holdings. 09%: Canada: 1. Company Change % Net. 50% vs. 7% vs -5. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. 94 per share, with $107. 8% of its total assets under management. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Royal Gold Inc. Therapeutics Gene Therapy CAR-T Cell Therapy CRSPR Gene Editing. Themes & Subsectors ETFs. Below is the comparison between BBH and XBI. Summary. Overview. 70% so far this year and is down about -16. 35% vs 0. XBI is an equal-weight passively-managed biotech ETF while ARKG is an actively-managed genomics ETF. 35%. 5% position, and no other holding accounts for more than 1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 08 per unit, that means that analysts see 59. Meanwhile, XBI equal weights its holdings. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. 7. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. View complete XBI exchange traded fund holdings for better informed ETF trading. 0 reviews. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. 06 as the 52 week high point — that compares with a last trade of $109. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. View Holdings As of 09/30/2023. So far this year, XBI has lost about -5. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. Download as Image. 3. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. 0. VEEV. XBI has traded between $73. The following charts reflect the geographic spread of WCLD's underlying holdings. 2, 2023. The Composition of the XBI is the Key. XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. 58. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. The sale of ETFs is subject to an activity assessment fee (from $0. Visitors trend 2W 10W 9M. XBI has lost 27. 03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. 264,458,476. In the institutional-holders-of-XBI table below, the initial column indicates the name of each top institutional holder of XBI, with a link to that fund's top holdings. 81 and $97. 1. Looking at the chart above, XBI's low point in its 52 week range is $62. Looking at the chart above, XBI's low point in its 52 week range is $62. 94 per share, with $121. XBI has an overall POWR Rating of D, equating to a Sell. Both FBT and XBI are ETFs. The company’s fifty day. iShares Biotechnology ETF ETF holdings by MarketWatch. 96%, and is down about -5. XBI vs BBH. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 81. Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. Learn everything about iShares Biotechnology ETF (IBB). XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. 4% of the stocks in our database. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). 51. Written by BNK Invest for BNK Invest ->. Name Symbol % Assets. We have highlighted five ETFs from different. 50. Below is the comparison between BBC and XBI. 76% allocation. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. Looking at the chart above, XBI's low point in its 52 week range is $72. A few losers won't cause XBI to crash. 81 and $97. No company usually makes up more than two percent of. Looking at the chart above, XBI's low point in its 52 week range is $62. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. underlying holdings of the fund. Fund size is a good indication of how many other investors trust this fund. 94 per share, with $116. The top 10 holdings of XBI look like this: XBI Top 10 Holdings (morningstar. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. All 142 XBI Holdings. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). 83%: Other: 0. In addition to holding 155 positions, its top 10 holdings make up just 14. 40. The top 10 holdings account for about 11. ARGX. ETF Channel Staff - Friday, October 20, 6:48 AM. . 19%. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 01 to $0. SPDR® S&P Biotech ETF XBI: NYSE Arca All Holdings as of 11/15/2023 Holdings are subject to change. 9. Message board - Online Community of active, educated investors researching and discussing Alaunos Therapeutics, Inc. The most heavily invested institutionals were Morgan Stanley ($614. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Skip to main content. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment ResearchLearn how it impacts everything we do. Taking a look at the XBI, it peaked at $174. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. The weighted harmonic average of closing market price divided by. Dividend Yield. 12% in the last one year (as of 03/16/2023). Both XBI and XLV are ETFs. 81 and $97. 12 and $91. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). 78% in the last one year. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). It can be found in the fund’s most recent prospectus. 10 as of November 2, 2022. 47 and a beta of 0. With about 151 holdings, it effectively. 47 million over the past three months. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. Follow. 36% of total assets under management. Meanwhile, XBI equal weights its holdings. 01 %IBB: iShares Biotechnology ETF: 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Currency in USD Follow 2W 10W 9M 72. Check out the side-by-side comparison table of XBI vs. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. Holdings. Currently, the. *Close price adjusted for splits. These are the positions, trades, and weight of all companies in her ARKK Innovation ETF. Performance and Risk The ETF has lost about -9. The weighted harmonic average of closing market price divided by. Both IBB and XBI are ETFs. Looking at the chart above, XBI's low point in its 52 week range is $100. ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. XBI. US. 07. Vertex Pharmaceuticals (VRTX 0. Also includes news, ETF details and other investing information. 06 as the 52 week high point — that compares with a last trade of $109. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. 95. XBI's top 10 holdings account for about 11. 35%). The weighted harmonic average of closing market price divided by. The gross expense ratio is the fund’s total annual operating expenses ratio. The top 10 holdings account for about 11. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). Net Expense Ratio. XBI: SPDR S&P Biotech ETF - Fund Holdings. ETFs are subject to market fluctuation and the risks of their underlying investments. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and. com. Monday's ETF Movers: XBI, QCLN. 1. The vast majority of XBI holdings have less than a 1% allocation in the fund. Performance and Risk. Chart. SPDR S&P Biotech ETF ETF holdings by MarketWatch. Expense ratio and liquidity are average for the group. XBI has traded between. 50. The company has an 88. 79 in February 2021 and has fallen over (50%) to $76. Discover historical prices for XBI stock on Yahoo Finance. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. 45% and is down about -9. 2% Top Ten Holdings. ETF Strategies. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. There is no guarantee the funds will achieve their stated investment objectives. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Trade XBI with: Price/Earnings ttm 17. Dollar Tree Inc. 7. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. The equal weight fund, designed to deliver. 6738M. Search tickers or categories. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . Looking at the chart above, XBI's low point in its 52 week range is $61. 49% weight in the XBI, are bumping into the $164 head resistance and are. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. 2. XBI SPDR S&P Biotech ETF ARKG ARK Genomic Revolution ETF IBB iShares Biotechnology ETF IHI iShares U. 1% vs 0. London. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. The fund’s NAV was $81. IBB has a higher 5-year return than XBI (0. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 06 and standard deviation of 38. Free ratings, analyses, holdings, benchmarks, quotes, and news. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Below is the comparison between IBB and XBI. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. 51 on Tuesday. XBI focuses on health care investments and follows the S&P Biotech Index. That's the main advantage to investing. SPDR® S&P Biotech ETF XBI: NYSE Arca . It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 58 💸. Performance and Risk The ETF has lost about -29. The top 10 holdings account for about 14. Year-to-date, the SPDR S&P Biotech ETF has lost about -15. 35% ; Sectors:. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). 01% vs 0. In its most recent earnings release, President and Chief Executive Officer Christopher A. 97 and standard deviation of 36. Looking at the chart above, XBI's low point in its 52 week range is $62. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 67. 12% over the last 12 months (as of 07/18/2023). Region Percentage; North, Central and South America: 99. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Holdings. Brazil. 5. ARKK ARKG. MTD. XBI is a modified equal weighted ETF with about 157 holdings, though that number may change due to issues such as being acquired, among others. Growth of Hypothetical $10,000. View and export this data back to 2006. com. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. View complete YINN exchange traded fund holdings for better informed ETF trading. TG Therapeutics Inc TGTX:US. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. 38% vs. Seeking AlphaXBI vs. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Themes & Subsectors ETFs. The top holding in XBI receives just a 1. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. 1% and 1. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. View complete XLV exchange traded fund holdings for better informed ETF trading. 0. 99%. Diversification. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. WIX. Sector ETFs. View complete IBB exchange traded fund holdings for. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). As of Oct 31 2023. SPDR® S&P Biotech ETF (XBI) latest earnings report: revenue, EPS, surprise, history, news and analysis. DLTR. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. View complete WCLD exchange traded fund holdings for better informed ETF trading. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI Holdings 5 Beaten-Down ETFs to Buy Now. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 8% of its total assets under management. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. 2B Total Assets 0. Top 10 Holdings 16. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. . XBI holdings. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 81% of the total fund's. Here, we set out to define in detail the pharmacokinetics of a well-characterized IDR molecule, IDR-1018. Looking at the chart above, XBI's low point in its 52 week range is $63. In seeking to track the performance of the S&P Biotechnology Select. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 81% and is down about -5. 97. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. 31 per share, with $92. Both ARKG and XBI are ETFs. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 1. 50(-0. Top 10 Holdings (14. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 13 and $94. XBI has a beta of 1. One of the ideas making the rounds on Wall Street right now (I’ve seen it commented on in a number of places) is buying XBI, the SPDR S&P Biotech ETF, at this time of year, for a spring rally. Below is the comparison between FBT and XBI. Front end load.